In the present preliminary case the consequence of the termination of the agreement between Medical Workshop and Sharpsight was that Medical Workshop was no longer able to use the name Invitria for the sale and marketing of the ophthalmalogic product protected by a patent owned by the single shareholder of Sharpsight.
Case date: 16 October 2019
Case number: C/09/575985 / KG ZA 19-581
Court: Provisions Judge of the District Court of The Hague
A full summary of this case has been published on Kluwer IP Law.